HOME > ARCHIVE

ARCHIVE

Over 50% of Directors of Private Hospitals Support Management by Stock Companies

July 26, 2004
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

July 26, 2004
Kyoso Mirai Group Considering Holding Company System: Mr Hamada of Toho

July 26, 2004
EPMA to Consider Affiliation with IGPA

July 26, 2004
BUSINESS NEWS IN BRIEF

July 26, 2004
TOPICS 2 articles

July 26, 2004
NEW PRODUCT

July 26, 2004
Semi-annual Business Results

July 26, 2004
GSK Developing Multiple Kinase Inhibitors: GSK Symposium 2004

July 26, 2004
WORLD NEWS IN BRIEF

July 26, 2004
PRESS SEMINAR

July 26, 2004
2 WG to Discuss Problems with Drug Distribution: Ryukaikon

July 26, 2004
RESEARCH & DEVELOPMENT NEWS IN BRIEF

July 26, 2004
Import of Zometa Inj 4 mg Approved

July 26, 2004
MEDICAL DEVICE NEWS IN BRIEF

July 26, 2004
Supplementary Notification on Amended PAL Issued

July 26, 2004
DIAGNOSTIC NEWS IN BRIEF

July 26, 2004
Korosho to Recommend Measures to Ensure Safe Blood Transfusion

July 19, 2004
PMDA Receives 1st Application for Priority Consultation Service

July 19, 2004
REGULATORY NEWS IN BRIEF

July 19, 2004

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Shift Underway in Pharma Workforce as Sales Roles Shrink, Manufacturing Rises

By Hayate Horiguchi

Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…

COLUMN

The Patient North Star: How Gilead Japan Redefined Innovation

By Philip Carrigan

In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…